No photo of Christopher J. Destache

View Scopus Profile

Christopher J. Destache, PharmD, FCCP

Professor

  • 2544 Citations
  • 26 h-Index
1985 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Christopher J. Destache is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Long-acting antiretroviral nanoparticles for HIV prophylaxis

Destache, C. J.

National Institutes of Health

2/4/15 → 1/31/18

Project: Research project

    • Once Monthly Antiretroviral Nanoparticles for HIV-1 Treatment

    Destache, C. J.

    National Institutes of Health

    6/15/11 → 5/31/13

    Project: Research project

    • Pharmacology of Antiretroviral Nanoparticle Micelles

    Destache, C. J.

    National Institutes of Health

    6/1/08 → 5/31/11

    Project: Research project

    • Research Output

    A potential long-acting bictegravir loaded nano-drug delivery system for HIV-1 infection: A proof-of-concept study

    Mandal, S., Prathipati, P. K., Belshan, M. & Destache, C. J., Jul 2019, In : Antiviral Research. 167, p. 83-88 6 p.

    Research output: Contribution to journal › Article

    • 5 Scopus citations

    A review of CCR5 antibodies against HIV: current and future aspects

    Prathipati, P. K., Mandal, S. & Destache, C. J., Feb 1 2019, In : Therapeutic Delivery. 10, 2, p. 107-112 6 p.

    Research output: Contribution to journal › Article

    • Ceftaroline fosamil for the treatment of Gram-positive endocarditis: CAPTURE study experience

    Destache, C. J., Guervil, D. J. & Kaye, K. S., Jan 1 2019, In : International Journal of Antimicrobial Agents.

    Research output: Contribution to journal › Article

    Open Access
    • 5 Scopus citations

    Correction to: Pharmacokinetic and Tissue Distribution Profile of Long Acting Tenofovir Alafenamide and Elvitegravir Loaded Nanoparticles in Humanized Mice Model (Pharmaceutical Research, (2017), 34, 12, (2749-2755), 10.1007/s11095-017-2255-7)

    Prathipati, P. K., Mandal, S., Pon, G., Vivekanandan, R. & Destache, C. J., Jul 1 2019, In : Pharmaceutical Research. 36, 7, 108.

    Research output: Contribution to journal › Comment/debate

    Open Access

    • Corrigendum to “Nanoencapsulation introduces long-acting phenomenon to tenofovir alafenamide and emtricitabine drug combination: A comparative pre-exposure prophylaxis efficacy study against HIV-1 vaginal transmission” [Journal of Controlled Release 294 (2019)216–225](S0168365918307302)(10.1016/j.jconrel.2018.12.027)

    Mandal, S., Kang, G., Prathipati, P. K., Zhou, Y., Fan, W., Li, Q. & Destache, C. J., Jun 28 2019, In : Journal of Controlled Release. 304, 1 p.

    Research output: Contribution to journal › Comment/debate